Lauri Tuominen , MD, PhD

Dr. Lauri Tuominen is a neuroscientist at The Royal’s Institute of Mental Health Research (IMHR), affiliated with the University of Ottawa.

Dr. Tuominen received his medical doctorate from the University of Turku in 2009 and his PhD in Psychiatric Neuroimaging from the Turku PET Centre and University of Turku in Finland in 2014. He completed his post-doctoral training in psychiatry at the Massachusetts General Hospital and Harvard Medical School, in Boston, Massachusett. He has received many grants and distinctions. Most recently, he received a Canadian Institutes of Health Research (CIHR) grant to improve understanding of cognitive impairments in people with schizophrenia alongside Dr. Synthia Guimond. Dr. Tuominen is also recipient of a J.P. Bickell Foundation grant,.

During his research career, Dr. Tuominen has investigated the neurobiology of various aspects of psychopathology and developed a unique expertise in combining positron emission tomography (PET) and magnetic resonance imaging (MRI). Presently, Dr. Tuominen’s research is focused on understanding schizophrenia using multimodal imaging methods, including positron emission tomography (PET) and functional MRI, and exploring how changes in dopamine and acetylcholine neurotransmitter systems underlie learning, and cognitive deficits in schizophrenia.